1 janv. 2011 - New event
Description:
The first-in-class gene therapy drug, pCMV-vegf165, is registered in Russia for the treatment of peripheral artery disease, including the advanced stage of critical limb ischemia. The United Nations declaration on non-communicable diseases (NCD's) changes the global approach to these diseases, of which cardiovascular disease is the greatest contributor.Ajouté au bande de temps:
Date:
1 janv. 2011
Maintenaint
~ Il y a 13 ans
